Sickle Cell Kidney Biorepository for Sickle Cell Disease and Trait
This study is creating a collection of blood and urine samples, called a biorepository, to better understand kidney disease in people with sickle cell disease (SCD) and sickle cell trait. Researchers want to learn how kidney disease starts and why it can be more severe in these conditions. This study is observational, meaning it collects information without testing new treatments. They plan to enroll up to 800 participants aged 18 to 65 who have sickle cell disease or sickle cell trait, and some control participants without these conditions. The main goals are to track changes in kidney function and albuminuria (a sign of kidney damage) over 10 years.
- Study design
- This is an observational study aiming to enroll up to 800 participants. It is not testing a specific drug or intervention.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' kidney function and albuminuria will be measured over 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Sickle Cell Kidney Biorepository
At a glance
Conditions
NCT07064174
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Parkland Memorial Hospital
Dallas, Texasstudy coordinator listed
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Kidney function decline10 years
Mean change in the estimated glomerular filtration rate per year
- Albuminuria10 years
Mean change in the urine albumin-to-creatinine ratio per year